跳至主要内容
临床试验/ISRCTN33084113
ISRCTN33084113已完成不适用

A two-centre randomised controlled trial investigating the effect of remote ischaemic preconditioning (RIPC) on blood and myocardial biomarkers of stress and injury-related signalling in patients having isolated coronary artery bypass grafting (CABG) or aortic valve replacement (AVR) using cardiopulmonary bypass (CPB)

Imperial College London (UK)0 个研究点目标入组 120 人开始时间: 2013年3月25日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Current inclusion criteria as of 03/11/2014:
  • 1. Age =18
  • 2. Patients undergoing elective (or urgent) first-time CABG or AVR
  • Previous inclusion criteria:
  • 1. Male and female, age >=40 and <85 years
  • 2. Patients undergoing elective (or urgent) first-time CABG or AVR

排除标准

  • Current exclusion criteria as of 03/11/2014:
  • 1. Cardiogenic shock or cardiac arrest,
  • 2. Significant peripheral arterial disease affecting upper limbs,
  • 3. Renal failure (with a GFR < 30 ml/min/1.73m2),
  • 4. Glibenclamide or nicorandil (as these medications may interfere with RIPC)
  • 5. Participation in another interventional study.
  • 6. Neither upper limb available for the intervention
  • Previous exclusion criteria:
  • 1. Cardiogenic shock or cardiac arrest
  • 2. Significant peripheral arterial disease affecting upper limbs
  • 3. Hepatic dysfunction (Bilirubin > 20 mmol/L, Prothrombin > 2.0 ratio)
  • 4. Pulmonary disease (FEV1 < 40% predicted)
  • 5. Renal failure (with a GFR < 30 ml/min/1.73m2)
  • 6. Glibenclamide or nicorandil (as these medications may interfere with RIPC)
  • 7. Participation in another interventional study

研究者

发起方
Imperial College London (UK)

相似试验